The beneficial effects of FGF21 on body weight, food intake and energy expenditure have resulted in substantial interest in FGF21 as a potential treatment for obesity and metabolic syndrome. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.